{
  "NLSP": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T12:32:46Z",
      "headline": "NLS Pharmaceutics And Kadimastem Join Forces To Revolutionize Diabetes Treatment With Multi-Target Approach Beyond GLP-1",
      "id": 43589518,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "NLSP"
      ],
      "updated_at": "2025-02-10T12:32:47Z",
      "url": "https://www.benzinga.com/news/25/02/43589518/nls-pharmaceutics-and-kadimastem-join-forces-to-revolutionize-diabetes-treatment-with-multi-target-a",
      "added_at": "2025-02-10T12:34:46.954Z"
    }
  ],
  "LFWD": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T12:21:11Z",
      "headline": "Laidlaw & Co. Initiates Coverage On Lifeward with Buy Rating, Announces Price Target of $10",
      "id": 43589224,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LFWD"
      ],
      "updated_at": "2025-02-10T12:21:12Z",
      "url": "https://www.benzinga.com/news/25/02/43589224/laidlaw-co-initiates-coverage-on-lifeward-with-buy-rating-announces-price-target-of-10",
      "added_at": "2025-02-10T12:38:33.879Z"
    }
  ],
  "GRCE": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T13:02:04Z",
      "headline": "Grace Therapeutics Announces Phase 3 STRIVE-ON Safety Trial Of GTx-104 In aSAH Met the Primary Endpoint",
      "id": 43590324,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "GRCE"
      ],
      "updated_at": "2025-02-10T13:02:05Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43590324/grace-therapeutics-announces-phase-3-strive-on-safety-trial-of-gtx-104-in-asah-met-the-primary-en",
      "added_at": "2025-02-10T13:04:47.735Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T13:11:06Z",
      "headline": "Grace Therapeutics Announces Up To $30M Private Placement With  Institutional Investors; Initial Upfront Funding ~$15M And Up To $15M Upon Exercise Of Accompanying Warrants",
      "id": 43590559,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "GRCE"
      ],
      "updated_at": "2025-02-10T13:11:07Z",
      "url": "https://www.benzinga.com/news/25/02/43590559/grace-therapeutics-announces-up-to-30m-private-placement-with-institutional-investors-initial-upfron",
      "added_at": "2025-02-10T13:14:48.203Z"
    },
    {
      "author": "Vandana Singh",
      "content": "",
      "created_at": "2025-02-10T17:05:59Z",
      "headline": "Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study",
      "id": 43600505,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/10/GRCE.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/10/GRCE.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/10/GRCE.png"
        }
      ],
      "source": "benzinga",
      "summary": "Grace Therapeutics&#39; GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.",
      "symbols": [
        "GRCE"
      ],
      "updated_at": "2025-02-10T17:06:00Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43600505/small-cap-grace-therapeutics-touts-positive-data-from-brain-hemorrhage-study",
      "added_at": "2025-02-10T17:09:53.237Z"
    }
  ],
  "FTEL": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T13:48:58Z",
      "headline": "Fitell Updated Registered Direct Offering For Up To $10.0M To Purchase Up To 1,195,220 Shares In The Form Of Warrants At $5.02/Share",
      "id": 43592000,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "FTEL"
      ],
      "updated_at": "2025-02-10T13:48:59Z",
      "url": "https://www.benzinga.com/news/25/02/43592000/fitell-updated-registered-direct-offering-for-up-to-10-0m-to-purchase-up-to-1-195-220-shares-in-the",
      "added_at": "2025-02-10T13:49:48.799Z"
    }
  ],
  "MNTS": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T14:03:38Z",
      "headline": "Momentus Has Been Awarded A Contract Expansion By The U.S. Department Of Defense Organization, DARPA, To Conduct An In-Orbit Demonstration Of The Assembly Of Large Scale Structures",
      "id": 43592416,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MNTS"
      ],
      "updated_at": "2025-02-10T14:04:26Z",
      "url": "https://www.benzinga.com/news/25/02/43592416/momentus-has-been-awarded-a-contract-expansion-by-the-u-s-department-of-defense-organization-the-def",
      "added_at": "2025-02-10T14:04:49.296Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T16:31:06Z",
      "headline": "Momentus Announces Pricing Of Its \"Reasonable Best Efforts\" Offering With A Single Institutional Investor For The Purchase And Sale Of 1,273,886 Shares Of Its Common Stock And Warrants To Purchase Up To 1,273,886 Shares Of Common Stock At A Combined Purchase Price Of $3.925",
      "id": 43599453,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MNTS"
      ],
      "updated_at": "2025-02-10T16:31:06Z",
      "url": "https://www.benzinga.com/news/25/02/43599453/momentus-announces-pricing-of-its-reasonable-best-efforts-offering-with-a-single-institutional-inves",
      "added_at": "2025-02-10T16:34:52.157Z"
    },
    {
      "author": "Shivani Kumaresan",
      "content": "",
      "created_at": "2025-02-10T17:47:41Z",
      "headline": "Momentus Wins Defense Department Contract Expansion, Stock Skyrockets",
      "id": 43601884,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/10/What-Consultants-Do.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/10/What-Consultants-Do.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/10/What-Consultants-Do.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": "Shares of Momentus are soaring after the company secured an expanded contract with DARPA for an in-orbit demonstration of large-scale structure assembly. ",
      "symbols": [
        "MNTS"
      ],
      "updated_at": "2025-02-10T17:47:41Z",
      "url": "https://www.benzinga.com/news/contracts/25/02/43601884/momentus-wins-defense-department-contract-expansion-stock-skyrockets",
      "added_at": "2025-02-10T17:49:53.765Z"
    }
  ],
  "MPAA": [
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-02-10T13:20:07Z",
      "headline": "Earnings Summary: Motorcar Parts of America Q3",
      "id": 43591076,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_2.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_2.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_2.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "MPAA"
      ],
      "updated_at": "2025-02-10T13:20:08Z",
      "url": "https://www.benzinga.com/insights/earnings/25/02/43591076/earnings-summary-motorcar-parts-of-america-q3",
      "added_at": "2025-02-10T14:18:41.541Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T13:06:25Z",
      "headline": "Motorcar Parts of America Q3 2025 Adj EPS $0.35 Misses $0.43 Estimate",
      "id": 43590467,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MPAA"
      ],
      "updated_at": "2025-02-10T13:06:26Z",
      "url": "https://www.benzinga.com/news/earnings/25/02/43590467/motorcar-parts-of-america-q3-2025-adj-eps-0-35-misses-0-43-estimate",
      "added_at": "2025-02-10T14:18:41.541Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T13:00:42Z",
      "headline": "Motorcar Parts of America Q3 Sales $186.18M Beat $179.50M Estimate",
      "id": 43590271,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MPAA"
      ],
      "updated_at": "2025-02-10T13:00:43Z",
      "url": "https://www.benzinga.com/news/earnings/25/02/43590271/motorcar-parts-of-america-q3-sales-186-18m-beat-179-50m-estimate",
      "added_at": "2025-02-10T14:18:41.541Z"
    }
  ],
  "AIOT": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T12:25:44Z",
      "headline": "Powerfleet Raised Its 2025 Outlook: Now Expects Revenue To Exceed $362.5M, Up $10M From Prior $352.5M Guidance And Adjusted EBITDA To Exceed $75M, Up $2.5M From Prior",
      "id": 43589310,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-10T12:25:45Z",
      "url": "https://www.benzinga.com/news/earnings/25/02/43589310/powerfleet-raised-its-2025-outlook-now-expects-revenue-to-exceed-362-5m-up-10m-from-prior-352-5m-gu",
      "added_at": "2025-02-10T14:36:22.145Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T12:22:33Z",
      "headline": "PowerFleet Q3 2024 Adj. EPS $0.01, Inline, Sales $106.429M Beat $99.426M Estimate",
      "id": 43589231,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-10T12:22:33Z",
      "url": "https://www.benzinga.com/news/earnings/25/02/43589231/powerfleet-q3-2024-adj-eps-0-01-inline-sales-106-429m-beat-99-426m-estimate",
      "added_at": "2025-02-10T14:36:22.145Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-02-10T12:20:13Z",
      "headline": "Earnings Summary: PowerFleet Q3",
      "id": 43589163,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_0.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_0.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_0.png"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-10T12:20:13Z",
      "url": "https://www.benzinga.com/insights/earnings/25/02/43589163/earnings-summary-powerfleet-q3",
      "added_at": "2025-02-10T14:36:22.145Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T16:40:59Z",
      "headline": "Barrington Research Maintains Outperform on PowerFleet, Maintains $15 Price Target",
      "id": 43599699,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-10T16:41:00Z",
      "url": "https://www.benzinga.com/news/25/02/43599699/barrington-research-maintains-outperform-on-powerfleet-maintains-15-price-target",
      "added_at": "2025-02-10T16:44:52.919Z"
    }
  ],
  "MVIS": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T12:14:51Z",
      "headline": "D. Boral Capital Initiates Coverage On Microvision with Buy Rating, Announces Price Target of $3",
      "id": 43588906,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MVIS"
      ],
      "updated_at": "2025-02-10T12:14:52Z",
      "url": "https://www.benzinga.com/news/25/02/43588906/d-boral-capital-initiates-coverage-on-microvision-with-buy-rating-announces-price-target-of-3",
      "added_at": "2025-02-10T14:39:55.298Z"
    }
  ],
  "DOMH": []
}